Meet the Team
Legacy BioDesign LLC was established in 2004 by Susan Manning, serving as President, and Dr. Mark Manning, in his role as Chief Scientific Officer. The core mission of Legacy BioDesign is to offer exceptional service in contract formulation and assay development to a global clientele, with a specialized emphasis on biopharmaceuticals.
Our core values include integrity, responsiveness, and creativity. The name of our company was chosen to convey our intention to leave a legacy of excellence and support of our clients. We look forward to collaborating with our clients in order to address their specific product development challenges, forging a lasting partnership.